Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation.

Agnieszka Kotalczyk Yu-Tao GuoYutang WangGregory Yoke Hong Lipnull On Behalf Of The ChiOTEAF Registry Investigators

Published in: Journal of clinical medicine (2022)

Multimorbidity and polypharmacy were common among elderly AF Chinese patients. Multimorbidity was an independent predictor of adverse clinical outcomes. The use of OAC was safe and significantly improved survival amongst AF patients with multimorbidity and polypharmacy.

Keyphrases

atrial fibrillation
adverse drug
middle aged
community dwelling
emergency department